4-oxo-1,4-dihydroquinoline-3-carboxamides derivatives as new potent and selective Cb2 agonists with anti-inflammatory and analgesic properties in the gut

被引:0
|
作者
Body-Malapel, Mathilde
El-Bakali, Jamal
Merour, Emilie
Stern, Eric
Millet, Regis
Desreumaux, Pierre
机构
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:A107 / A107
页数:1
相关论文
共 50 条
  • [1] Pharmacomodulations around the 4-oxo-1,4-dihydroquinoline-3-carboxamides, a class of potent CB2-selective cannabinoid receptor ligands:: Consequences in receptor affinity and functionality
    Stern, Eric
    Muccioli, Giulio G.
    Bosier, Barbara
    Hamtiaux, Laurie
    Millet, Regis
    Poupaert, Jacques H.
    Henichart, Jean-Pierre
    Depreux, Patrick
    Goossens, Jean-Francois
    Lambert, Didier M.
    JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (22) : 5471 - 5484
  • [2] Novel 4-oxo-1,4-dihydroquinoline-3-carboxamide derivatives as new CB2 cannabinoid receptors agonists:: Synthesis, pharmacological properties and molecular modeling
    Stern, E
    Muccioli, GG
    Millet, R
    Goossens, JF
    Farce, A
    Chavatte, P
    Poupaert, JH
    Lambert, DM
    Depreux, P
    Hénichart, JP
    JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (01) : 70 - 79
  • [3] CoMFA and CoMSIA analyses on 4-oxo-1,4-dihydroquinoline and 4-oxo-1,4-dihydro-1,5-,-1,6-and-1,8-naphthyridine derivatives as selective CB2 receptor agonists
    Cichero, Elena
    Cesarini, Sara
    Mosti, Luisa
    Fossa, Paola
    JOURNAL OF MOLECULAR MODELING, 2010, 16 (04) : 677 - 691
  • [4] CoMFA and CoMSIA analyses on 4-oxo-1,4-dihydroquinoline and 4-oxo-1,4-dihydro-1,5-, -1,6- and -1,8-naphthyridine derivatives as selective CB2 receptor agonists
    Elena Cichero
    Sara Cesarini
    Luisa Mosti
    Paola Fossa
    Journal of Molecular Modeling, 2010, 16 : 677 - 691
  • [5] Imine derivatives as new potent and selective CB2 cannabinoid receptor agonists with an analgesic action
    Ohta, Hiroshi
    Ishizaka, Tomoko
    Tatsuzuki, Makoto
    Yoshinaga, Mitsukane
    Iida, Izumi
    Yamaguchi, Tomomi
    Tomishima, Yasumitsu
    Futaki, Nobuko
    Todac, Yoshihisa
    Saito, Shuji
    BIOORGANIC & MEDICINAL CHEMISTRY, 2008, 16 (03) : 1111 - 1124
  • [6] Benzo[d]thiazol-2(3H)-ones as new potent selective CB2 agonists with anti-inflammatory properties
    Leleu-Chavain, Natascha
    Baudelet, Davy
    Heloire, Valeria Moas
    Rocha, Diana Escalante
    Renault, Nicolas
    Barczyk, Amelie
    Djouina, Madjid
    Body-Malapel, Mathilde
    Carato, Pascal
    Millet, Regis
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2019, 165 : 347 - 362
  • [7] 4-Oxo-1,4-dihydroquinoline-3-carboxamide Derivatives as New Axl Kinase Inhibitors
    Tan, Li
    Zhang, Zhang
    Gao, Dongylin
    Luo, Jinfeng
    Tu, Zheng-Chao
    Li, Zhengqiu
    Peng, Lijie
    Ren, Xiaomei
    Ding, Ke
    JOURNAL OF MEDICINAL CHEMISTRY, 2016, 59 (14) : 6807 - 6825
  • [8] Sulfonamide derivatives as new potent and selective CB2 cannabinoid receptor agonists
    Ohta, Hiroshi
    Ishizaka, Tomoko
    Yoshinaga, Mitsukane
    Morita, Aki
    Tomishima, Yasumitsu
    Toda, Yoshihisa
    Saitoa, Shuj
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (18) : 5133 - 5135
  • [9] N,1-dialkyl-7-(alkylamino)-4-( alkylimino)-1,4-dihydroquinoline-3-carboxamides and their 4-oxo derivatives:: Synthesis and properties
    van Es, T
    Staskun, B
    SOUTH AFRICAN JOURNAL OF CHEMISTRY-SUID-AFRIKAANSE TYDSKRIF VIR CHEMIE, 2001, 54 : 1 - 16
  • [10] Design of 4-Oxo-1-aryl-1,4-dihydroquinoline-3-carboxamides as Selective Negative Allosteric Modulators of Metabotropic Glutamate Receptor Subtype 2
    Felts, Andrew S.
    Rodriguez, Alice L.
    Smith, Katrina A.
    Engers, Julie L.
    Morrison, Ryan D.
    Byers, Frank W.
    Blobaum, Anna. L.
    Locuson, Charles W.
    Chang, Sichen
    Venable, Daryl F.
    Niswender, Colleen M.
    Daniels, J. Scott
    Conn, P. Jeffrey
    Lindsley, Craig W.
    Emmitte, Kyle A.
    JOURNAL OF MEDICINAL CHEMISTRY, 2015, 58 (22) : 9027 - 9040